ArticleScientific reports2025
Climate and landscape drivers of a mosquito-borne pathogen in an iconic game bird in the eastern and upper midwestern USA.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The ruffed grouse (Bonasa umbellus) is a non-migratory upland game bird that inhabits young and mature forests in the USA and Canada. Population indices in some portions of its range, particularly the eastern USA, have been in decline since the arrival of West Nile virus (WNV), a mosquito-borne Flavivirus. Subsequent experimental research suggested that WNV may cause morbidity and/or mortality in up to 90% of grouse, which had similar clinicopathologic findings to naturally-infected grouse. Additionally, WNV serosurveys in Pennsylvania revealed low seroprevalence concurrent with elevated vector indices. To further elucidate aspects of WNV epidemiology in ruffed grouse, we tested hunter-collected filter paper strips for anti-WNV antibodies in 15 states during fall-winter, 2018-2022. Annual total seroprevalence ranged from 12.0% in 2019-2020 to 17.9% in 2021-2022. We assessed for associations between county-level WNV seroprevalence and large-scale climate, environmental, and landscape variables through Bayesian multilevel modeling, accounting for spatial autocorrelation. The top model suggested that WNV seroprevalence was positively correlated with summer precipitation; the second most supported model suggested similar findings of positive correlation between WNV seroprevalence and spring precipitation. Management strategies should prioritize understanding factors that influence mosquito-borne pathogen transmission in conjunction with providing more forested habitat of high quality for ruffed grouse to optimize survival in the face of WNV and other challenges.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.